Lifecore Biomedical, Inc. De (LFCR) Gross Margin (2010 - 2025)

Lifecore Biomedical's Gross Margin history runs 16 years deep, the most recent figure standing at 38.37% for Q2 2025.

• In Q2 2025, Gross Margin fell 722.0% year-over-year to 38.37%; the TTM figure through May 2025 stood at 31.27% (down 136.0% YoY), while the FY2025 annual figure was 31.27%, down 136.0% from the prior year.
• Gross Margin was 38.37% for Q2 2025 at Lifecore Biomedical, up from 28.01% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 45.59% in Q2 2024 to a low of 11.12% in Q3 2023.
• Historically, Gross Margin has averaged 31.39% across 5 years, with a median of 32.74% in 2023.
• The sharpest annual moves came in 2021 and 2022: Gross Margin jumped 2620 bps in 2021, then slumped 1878 bps in 2022.
• A 5-year view of Gross Margin shows it stood at 44.76% in 2021, then slumped by 42 bps to 25.97% in 2022, then rose by 27 bps to 33.02% in 2023, then advanced by 3 bps to 34.04% in 2024, then gained by 13 bps to 38.37% in 2025.
• The last three Gross Margin figures came in at 38.37% (Q2 2025), 28.01% (Q1 2025), and 34.04% (Q4 2024), per Business Quant data.